Drug Relief v1— 510(k) K221231

Substantially Equivalent

Dyansys, Inc.

FDA 510(k) clearance K221231 for Drug Relief v1, Substantially Equivalent on 2022-06-06. Applicant: Dyansys, Inc.. Device class: 2.

Clearance details

Applicant: Dyansys, Inc.
Product code: Code PZR
Device class: Class 2
Regulation: 21 CFR 882.5896
Advisory panel: Neurology
Date received: 2022-04-29
Decision date: 2022-06-06
Decision: Substantially Equivalent
Clearance type: Special
Location: San Mateo, CA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code PZR

K251246 — Sparrow Ascent2025-08-25
K233166 — NET Recovery Corp/NET Device2024-05-29
K230796 — Sparrow Ascent2023-06-20
K211971 — Drug Relief v12021-11-05
K201873 — Sparrow Therapy System2021-01-02

More clearances from Dyansys, Inc.

Data sourced from openFDA. This site is unofficial and independent of the FDA.